Management of Extrapyramidal Symptoms

Introduction to Anticholinergic Medications

• The American Academy of Family Physicians recommends that anticholinergic medications should generally be avoided in elderly patients due to increased risk of cognitive impairment 1

Medication Equivalence and Potency

• Benztropine 2 mg is the equivalent dose for trihexyphenidyl 5 mg when treating extrapyramidal symptoms, based on their relative potency at muscarinic receptors 1

Pharmacokinetics and Tolerability

• Benztropine has a longer half-life (24-48 hours) compared to trihexyphenidyl (5-10 hours), and may be better tolerated in some patients due to less peripheral anticholinergic effects 1

Dosage and Administration

• The National Comprehensive Cancer Network recommends starting at a lower dose (benztropine 0.5-1 mg) and considering alternative treatments if tardive dyskinesia is present, and maintaining or increasing the benztropine dose as needed if dystonic reactions occur 2

Monitoring and Adverse Effects

• Patients on anticholinergic medications should be monitored for changes in EPS control, anticholinergic side effects (such as dry mouth, blurred vision, constipation, and urinary retention), and cognitive effects, particularly in elderly patients 1

Alternative Treatments

• For patients who cannot tolerate either medication, consider alternative treatments such as amantadine (which has a lower anticholinergic burden), dose reduction of the causative antipsychotic, or switching to an atypical antipsychotic with lower EPS risk 2